Principal Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-370
Closed -$3.95K 2814
2025
Q3
$3.95K Buy
370
+124
+50% +$1.22K ﹤0.01% 3032
2025
Q2
$2.38K Sell
246
-23
-9% -$237 ﹤0.01% 3089
2025
Q1
$4.01K Hold
269
﹤0.01% 2845
2024
Q4
$4.01K Buy
269
+42
+19% +$684 ﹤0.01% 2842
2024
Q3
$4.34K Sell
227
-362
-61% -$7.5K ﹤0.01% 2725
2024
Q2
$12.2K Buy
589
+148
+34% +$2.94K ﹤0.01% 2306
2024
Q1
$8.29K Buy
441
+235
+114% +$4.03K ﹤0.01% 2430
2023
Q4
$2.97K Buy
+206
New +$2.8K ﹤0.01% 2705

Other funds holding OGN

Principal Securities's OGN Position: Q4 2025 in Review

Principal Securities sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 370 shares — an estimated $3.95K sold.

Principal Securities first reported a position in OGN in Q4 2023 and held it in 8 quarters. The position peaked at $12.2K in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Principal Securities reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 370 Organon & Co shares in Q4 2025, an estimated $3.95K.
  • Principal Securities first reported a position in Organon & Co in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Organon & Co position peaked at $12.2K in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.